跳至主要内容
临床试验/ACTRN12612000994886
ACTRN12612000994886已完成4 期

In children under five with WHO defined non-severe pneumonia, is three days of oral cotrimoxazole have the same efficacy than five days of oral cotrimoxazole in reducing fast breathing?

The University of Colorado at Denver and The Children’s Hospital0 个研究点目标入组 2,000 人开始时间: 2012年9月17日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
2,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
2 Months 至 59 Months(—)
性别
All

入选标准

  • The inclusion criteria were: children aged 2-59 months with WHO defined non-severe pneumonia

排除标准

  • - children with WHO defined severe or very severe pneumonia or any other severe disease
  • - children with a history of an allergic reaction to cotrimoxazole or three or more episodes of wheeze or current diagnosis of acute asthma
  • - those who had been enrolled earlier in the study; required antibiotics for any other condition; had been hospitalized in the previous 2 weeks or who had severe malnutrition.

研究者

发起方
The University of Colorado at Denver and The Children’s Hospital

相似试验

Treatment of World Health Organization (WHO) defined... | 临床试验